Figure 3.
Design of novel HDAC/MDM2 dual inhibitors via merging pharmacophores. (A) HDAC pharmacophores; (B) The binding forms of MDM2 inhibitor; (C) Merged pharmacophores.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.